Pharma Pulse 4/17/25: Pharma Companies Expected to Absorb Any Tariff Hit in Short Term, New Chronic Antigen Exposure Data, & more

Pharma companies expected to absorb any tariff hit in short term

While US tariffs on pharmaceuticals may eventually raise drug prices, especially for generics, experts say brand-name costs will likely be absorbed by manufacturers in the short term—impacting profits, research, and staffing—while the broader goal may be to pressure companies into narrowing the price gap between the US and other countries.

New Data Links Chronic Antigen Exposure to Immune Dysfunction in Post-Acute Syndromes

Nigel McCracken, chief operating officer, Virax Biolabs, discusses results from new data on the role of T cell dysfunction in post-acute infection syndromes.

Ten Years of Telemedicine-Based Prescribing Leads to Lawsuit

A Virginia patient and her husband filed a lawsuit against a Pennsylvania physician and pharmacy after nearly a decade of telemedicine-based care involving dangerously high corticosteroid prescriptions, with the court allowing the case to proceed based on allegations of reckless and extreme conduct that could support claims of negligence, emotional distress, and punitive damages.

Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG

Glycomine has raised $115 million in Series C financing to advance GLM101, a first-in-class mannose-1-phosphate replacement therapy for PMM2-CDG, into a Phase 2b trial, following encouraging Phase 2 data showing clinically meaningful improvements in ataxia among treated patients.

DHL Bids to Boost Healthcare Logistics with Singapore Hub

DHL Supply Chain has launched a $11.3 million Pharma Hub in Singapore as part of its $569 million Asia Pacific expansion, enhancing temperature-controlled logistics for life sciences and healthcare to meet rising regional demand and support the global distribution of critical medical products.

Have news you want us to share in Pharma Pulse? Reach out to Associate Editor Don Tracy. He can be reached at [email protected]